Excess body weight results in significant loss of the quality of life. Pathological obesity takes threatening forms worldwide, because of inevitable co-existing serious disease development.
The most severe related diseases are hypertension, diabetes, reproductive dysfunction, leg joint diseases, dyslipidemia (elevated level of cholesterol and blood triglyceride), varicose veins of lower limbs, sleep hypoventilation syndrome (sleep apnea), fatty liver dystrophy (hepatosis), chronic calculous cholecystitis, and chronic pancreatitis.
The increase in the number of people suffering from overweight is a problematic phenomenon worldwide. Most of the experts relate this problem to intense urbanisation and modernisation processes, accompanied by the general increase of physical inactivity and unhealthy eating habits.
The most common methods of weight loss are physical activity, dieting, nutritional supplements and medication. The last hope for people suffering from serious morbid forms of obesity is treatment by surgery. Obesity surgery is called Bariatric surgery. The most widely spread method of surgical obesity treatment is the procedure of gastric balloon placement. The popularity of this procedure is determined by its low invasiveness, atraumatic course and high efficiency. Merlin Med (Pty) Ltd partnered with SC MEDSIL, a Russian based research and development specialist founded in 1992, for the procurement and supply of specialised surgical medical products relating to Bariatric medical procedures.